Balyasny Asset Management
TENX icon

Balyasny Asset Management’s Tenax Therapeutics TENX Stock Holding History

Balyasny Asset Management’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.11M Buy
+194,616
New +$2.63M ﹤0.01% 1584
2022
Q4 		– Sell
-6
Closed -$2K – 3233
2022
Q3 		$2K Buy
+6
New +$2.41K ﹤0.01% 2770

Other funds holding TENX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Balyasny Asset Management's TENX Position: Q1 2026 in Review

Balyasny Asset Management opened a new position in Tenax Therapeutics (TENX) in Q1 2026: 194,616 shares worth $3.11M. The stake represents ﹤0.01% of the portfolio and ranks #1584 among its holdings. This is a return to the name: Balyasny Asset Management previously reported a position in TENX as recently as Q3 2022.

Balyasny Asset Management first reported a position in TENX in Q3 2022 and has held it in 2 quarters since. 80 funds tracked by Wall St. Rank hold TENX as of Q1 2026.

  • Balyasny Asset Management held 194,616 shares of Tenax Therapeutics worth $3.11M as of Q1 2026.
  • Tenax Therapeutics was a new Balyasny Asset Management position in Q1 2026.
  • Tenax Therapeutics made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1584 holding.
  • Balyasny Asset Management first reported a position in Tenax Therapeutics in Q3 2022 and has held it in 2 quarters since.
  • 80 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.